| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
26,320,000 |
| Market
Cap: |
3.83(M) |
| Last
Volume: |
169,426 |
Avg
Vol: |
168,966 |
| 52
Week Range: |
$0.1454 - $0.1454 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bupp David C |
CEO and President |
• • – |
2010-11-15 |
4 |
B |
$1.76 |
$26,450 |
D/D |
15,000 |
995,649 |
2.81 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2010-11-15 |
4 |
B |
$1.73 |
$26,080 |
D/D |
15,000 |
238,300 |
2.39 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2010-11-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,000) |
940,649 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2010-06-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
980,649 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2010-06-17 |
4 |
OE |
$0.41 |
$36,900 |
D/D |
90,000 |
1,010,649 |
|
- |
|
| Miller Fred B |
Director |
– • – |
2010-06-16 |
4 |
B |
$1.56 |
$15,600 |
I/I |
10,000 |
91,000 |
2.1 |
- |
|
| Johnson Owen E |
Director |
– • – |
2010-03-19 |
4 |
B |
$1.90 |
$19,000 |
D/D |
10,000 |
45,000 |
2.39 |
- |
|
| Avital Reuven |
Director |
– • – |
2010-03-16 |
4 |
B |
$2.10 |
$21,000 |
D/D |
10,000 |
150,000 |
2.39 |
- |
|
| Whitley J Frank |
Director |
– • – |
2009-12-30 |
4 |
OE |
$0.50 |
$15,000 |
D/D |
30,000 |
61,500 |
|
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2009-12-22 |
4 |
B |
$1.07 |
$214 |
I/I |
200 |
200 |
2.02 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2009-12-16 |
4 |
D |
$1.17 |
$32,586 |
D/D |
(27,851) |
890,649 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2009-12-16 |
4 |
OE |
$0.50 |
$22,500 |
D/D |
45,000 |
918,500 |
|
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2009-11-24 |
4 |
B |
$1.00 |
$7,000 |
D/D |
7,000 |
217,100 |
2.39 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2009-11-23 |
4 |
B |
$1.04 |
$10,400 |
D/D |
10,000 |
873,500 |
2.81 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2009-11-20 |
4 |
B |
$1.04 |
$21,125 |
D/D |
20,000 |
863,500 |
2.81 |
- |
|
| Larson Brent L |
VP Finance and CFO |
• – – |
2009-10-22 |
4 |
D |
$1.20 |
$44,050 |
D/D |
(36,708) |
123,292 |
|
- |
|
| Larson Brent L |
VP Finance and CFO |
• – – |
2009-10-22 |
4 |
OE |
$0.50 |
$30,000 |
D/D |
60,000 |
160,000 |
|
- |
|
| Brown Rodger A |
Vice President |
• – – |
2009-09-16 |
4 |
S |
$1.20 |
$36,000 |
D/D |
(30,000) |
5,000 |
|
- |
|
| Brown Rodger A |
Vice President |
• – – |
2009-09-16 |
4 |
OE |
$0.50 |
$17,500 |
D/D |
35,000 |
35,000 |
|
- |
|
| Johnson Owen E |
Director |
– • – |
2009-08-14 |
4 |
B |
$1.31 |
$20,220 |
D/D |
15,000 |
35,000 |
2.39 |
- |
|
| Avital Reuven |
Director |
– • – |
2009-06-11 |
4 |
B |
$0.95 |
$21,185 |
D/D |
22,300 |
140,000 |
2.39 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2009-06-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
193,746 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2009-06-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
843,500 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2009-06-08 |
4 |
OE |
$0.30 |
$30,000 |
D/D |
70,000 |
893,500 |
|
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2009-06-08 |
4 |
B |
$1.01 |
$404 |
D/D |
400 |
210,100 |
2.31 |
- |
|
411 Records found
|
|
Page 13 of 17 |
|
|
